PeopleIn: Growth continues, but at a moderated pace
About the author:
- Author name:
- By Liam Schofield
- Job title:
- Date posted:
- 28 August 2023, 8:00 AM
- Sectors Covered:
- Whilst the result was a slight miss against guidance and Factset consensus, PeopleIn (ASX:PPE) continued to deliver earnings growth (FY23 EBITDA: +29.5%) through a combination of organic growth (+8.3%) and acquisitions (acquired c.$15m of EBITDA in FY22). Despite FY23 presenting a number of operational challenges (nurse visa approval rates | IT recruitment), the company continued to see demand for its services, driven by continued low levels of unemployment, solid wage inflation and jobs growth across its diversified exposure to what remains a range of high demand sectors.
- At an FY24f PER (NPATA) of c.7.3x (8.8x NPAT), +90% cash conversion and growing organically at c.8% pa (plus acquisition growth) PPE remains cheap. It is on this basis that we retain our ADD rating with a slightly reduced target price of (login to view).
Find out more
Download full research note
You can find further detailed analysis of company results this reporting season by browsing our reporting season tag, and view a full list of upcoming results on our Reporting Season Calendar.
If you would like more information, please contact your adviser or nearest Morgans office.
Request a call
Find local branch
Disclaimer: The information contained in this report is provided to you by Morgans Financial Limited as general advice only, and is made without consideration of an individual's relevant personal circumstances. Morgans Financial Limited ABN 49 010 669 726, its related bodies corporate, directors and officers, employees, authorised representatives and agents (“Morgans”) do not accept any liability for any loss or damage arising from or in connection with any action taken or not taken on the basis of information contained in this report, or for any errors or omissions contained within. It is recommended that any persons who wish to act upon this report consult with their Morgans investment adviser before doing so.
Print this page